Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors.

Schütte M, Risch T, Abdavi-Azar N, Boehnke K, Schumacher D, Keil M, Yildiriman R, Jandrasits C, Borodina T, Amstislavskiy V, Worth CL, Schweiger C, Liebs S, Lange M, Warnatz HJ, Butcher LM, Barrett JE, Sultan M, Wierling C, Golob-Schwarzl N, Lax S, Uranitsch S, Becker M, Welte Y, Regan JL, Silvestrov M, Kehler I, Fusi A, Kessler T, Herwig R, Landegren U, Wienke D, Nilsson M, Velasco JA, Garin-Chesa P, Reinhard C, Beck S, Schäfer R, Regenbrecht CR, Henderson D, Lange B, Haybaeck J, Keilholz U, Hoffmann J, Lehrach H, Yaspo ML

Open source

DOI
10.1038/ncomms14262
Published
2017 Feb 10
Container
Nature communications
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/ncomms14262,
  title = {Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors.},
  author = {Schütte M and Risch T and Abdavi-Azar N and Boehnke K and Schumacher D and Keil M and Yildiriman R and Jandrasits C and Borodina T and Amstislavskiy V and Worth CL and Schweiger C and Liebs S and Lange M and Warnatz HJ and Butcher LM and Barrett JE and Sultan M and Wierling C and Golob-Schwarzl N and Lax S and Uranitsch S and Becker M and Welte Y and Regan JL and Silvestrov M and Kehler I and Fusi A and Kessler T and Herwig R and Landegren U and Wienke D and Nilsson M and Velasco JA and Garin-Chesa P and Reinhard C and Beck S and Schäfer R and Regenbrecht CR and Henderson D and Lange B and Haybaeck J and Keilholz U and Hoffmann J and Lehrach H and Yaspo ML},
  year = {2017},
  journal = {Nature communications},
  doi = {10.1038/ncomms14262},
  url = {https://doi.org/10.1038/ncomms14262}
}

RIS

TY  - JOUR
TI  - Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors.
AU  - Schütte M
AU  - Risch T
AU  - Abdavi-Azar N
AU  - Boehnke K
AU  - Schumacher D
AU  - Keil M
AU  - Yildiriman R
AU  - Jandrasits C
AU  - Borodina T
AU  - Amstislavskiy V
AU  - Worth CL
AU  - Schweiger C
AU  - Liebs S
AU  - Lange M
AU  - Warnatz HJ
AU  - Butcher LM
AU  - Barrett JE
AU  - Sultan M
AU  - Wierling C
AU  - Golob-Schwarzl N
AU  - Lax S
AU  - Uranitsch S
AU  - Becker M
AU  - Welte Y
AU  - Regan JL
AU  - Silvestrov M
AU  - Kehler I
AU  - Fusi A
AU  - Kessler T
AU  - Herwig R
AU  - Landegren U
AU  - Wienke D
AU  - Nilsson M
AU  - Velasco JA
AU  - Garin-Chesa P
AU  - Reinhard C
AU  - Beck S
AU  - Schäfer R
AU  - Regenbrecht CR
AU  - Henderson D
AU  - Lange B
AU  - Haybaeck J
AU  - Keilholz U
AU  - Hoffmann J
AU  - Lehrach H
AU  - Yaspo ML
PY  - 2017
JO  - Nature communications
DO  - 10.1038/ncomms14262
UR  - https://doi.org/10.1038/ncomms14262
ER  -

APA

M, S., T, R., N, A., K, B., D, S., M, K., R, Y., C, J., T, B., V, A., CL, W., C, S., S, L., M, L., HJ, W., LM, B., JE, B., M, S., C, W., N, G., S, L., S, U., M, B., Y, W., JL, R., M, S., I, K., A, F., T, K., R, H., U, L., D, W., M, N., JA, V., P, G., C, R., S, B., R, S., CR, R., D, H., B, L., J, H., U, K., J, H., H, L., & ML, Y. (2017). Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors.. Nature communications. https://doi.org/10.1038/ncomms14262

Source records